BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/25/2025 6:14:40 AM | Browse: 110 | Download: 446
 |
Received |
|
2024-12-03 15:00 |
|
Peer-Review Started |
|
2024-12-03 15:00 |
|
First Decision by Editorial Office Director |
|
2025-01-03 09:54 |
|
Return for Revision |
|
2025-01-03 09:54 |
|
Revised |
|
2025-01-16 08:19 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-01-21 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-01-21 09:50 |
|
Articles in Press |
|
2025-01-21 09:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-02-08 03:17 |
|
Publish the Manuscript Online |
|
2025-02-25 06:14 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-You Lian, Chen-Xiao Huang, Qin-Fen Chen and Xiao-Dong Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Wenzhou Science Technology Bureau Foundation |
2022Y0726 |
|
| Corresponding Author |
Xiao-Dong Zhou, MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Lane, Wenzhou 325000, Zhejiang Province, China. zhouxiaodong@wmu.edu.cn |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Heart failure; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; Sodium-glucose cotransporter 2 inhibitors |
| Core Tip |
The coexistence of heart failure with preserved ejection fraction (HFpEF) and metabolic dysfunction-associated steatotic liver disease (MASLD), poses significant clinical challenges due to their intricate relationship and similar metabolic pathophysiology. Clinical management strategies for HFpEF and MASLD still faces challenges. Sodium-glucose cotransporter 2 inhibitors showing benefits in HFpEF or MASLD, while other drugs, such as glucagon-like peptide-1 receptor agonists and statins remains under investigation. A holistic, patient-centered approach combining metabolic and cardiovascular care is vital for improving HFpEF and MASLD outcomes in global metabolic health challenges. |
| Publish Date |
2025-02-25 06:14 |
| Citation |
Lian LY, Huang CX, Chen QF, Zhou XD. Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution. World J Cardiol 2025; 17(2): 103845 |
| URL |
https://www.wjgnet.com/1949-8462/full/v17/i2/103845.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v17.i2.103845 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
